Member access

4-Traders Homepage  >  Shares  >  Italian Stock Exchange  >  DiaSorin SpA    DIA   IT0003492391

DIASORIN SPA (DIA)

12
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Italian Stock Exchange
10/15/2014 10/16/2014 10/17/2014 10/20/2014 10/21/2014 Date
28.98(c) 28.31(c) 28.36(c) 27.69(c) 28.21(c) Last
63 629 43 510 42 016 47 374 130 375 Volume
+0.76% -2.31% +0.18% -2.36% +1.88% Change
More quotes
Company
DiaSorin SpA engages in the development and distribution of medical devices.It operates through the Immunodiagnostics and Molecular Diagnostics segments.The Immunodiagnostics segment develops, produces, and markets immunoreagent kits.The Molecular Diagnostics segment supplies end laboratories with... 
Surperformance© rating of DiaSorin SpA
Trading Rating : Investor Rating :
More about the company
Chart DIASORIN SPA
Duration : Period :
DiaSorin SpA Technical Analysis Chart | DIA | IT0003492391 | 4-Traders
Full-screen chart
Financials (€)
Sales 2014 443 M
EBIT 2014 135 M
Net income 2014 84,6 M
Finance 2014 154 M
Yield 2014 1,73%
Sales 2015 470 M
EBIT 2015 147 M
Net income 2015 91,7 M
Finance 2015 214 M
Yield 2015 1,88%
PER 2014 18,31
PER 2015 16,67
EV / Sales 2014 3,21x
EV / Sales 2015 2,90x
Capitalization 1 578 M
More Financials
Latest news on DIASORIN SPA
09/18 DIASORIN : launches the stool test for Adenovirus on LIAISON
08/28 DIASORIN : Announces New Webinar in Their Annual Vitamin D Series
08/01 DIASORIN : The Board of Directors approves the results for H1'14
07/22 DIASORIN : Confirms its eligibility for the pea-pme
06/03 DIASORIN : launches the test for Vitamin D 1,25 on LIAISON
05/19 DIASORIN SPA : ex-dividend day for annual dividend
05/09 DIASORIN : The Board of Directors approves the results for Q1'14
05/06DIASORIN SPA : quaterly earnings release
04/03 DIASORIN : Special Notice - Notice of Intent to Sole Source Annual Maint/Service..
03/08 DIASORIN SPA : Provision of Laboratory reagents
03/06 DIASORIN SPA : The Board of Directors approves the results for FY'13
02/18 DIASORIN SPA : DiaSorin launches the new test for PTH on LIAISON
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF